Skip to content. Skip to navigation
Personal tools
  Members Area  

ANZCA

Sections
You are here: Home Events ANZCA Annual Scientific Meetings 2008 ASM Abstracts Sevoflurane versus other general anaesthesia on postoperative behaviour disturbance in children
Navigation
News
02-09-2008
September 2008 Trial Resource
Online trial
28-08-2008
August 2008
24-08-2008
New drug
A new drug has just been approved for use in Australia. SITAGLIPTIN (Januvia) is an oral drug for type 2 Diabetes mellitus. It is a new class of drug, a dipeptidyl peptidase (DPP-4) inhibitor. Sitagliptin is an 'incretin enhancer' that increases the levels of active incretin by inhibiting their metabolism by DPP-4, thus prolonging their effect in stimulating insulin release and decreasing glucagon secretion.
24-08-2008
Latest ANZCA e-newsletter online
The latest edition of ANZCA’s e-newsletter has now been emailed to Fellows, trainees and ANZCA staff.
21-08-2008
Fellowship Affairs
The first meeting of the Fellowship Affairs Committee was held on Friday, 15 August 2008. Chaired by Dr Margaret Cowling, the Committee oversees all matters directly pertinent to Fellows, including CPD, annual scientific meetings, Regional CME and SIG events, communications and professional issues
More news…
 
Document Actions

Sevoflurane versus other general anaesthesia on postoperative behaviour disturbance in children

Allan M Cyna1,2,3, Kate Stephens1, Penny Strickland2, Jessica N Larsson2, Philippa Middleton3

1Department of Women's Anaesthesia, Women's and Children's Hospital, Adelaide, Australia
2Department of Paediatric Anaesthesia, Women's and Children's Hospital, Adelaide, Australia
3Discipline of Obstetrics and Gynaecology, The University of Adelaide, Adelaide, Australia

Purpose of study: To compare sevoflurane with other general anaesthetic agents with or without pharmacological adjuncts with regards to paediatric postoperative behavioural disturbance in PACU.

Methods: We searched the Cochrane Library and other electronic databases in November 2007, for randomized or quasi-randomized controlled trials of children < 18 years presenting for general anaesthesia (GA). We included any sevoflurane anaesthetic +/- nitrous oxide compared with any other (GA). Types of GA included: other volatiles e.g. isoflurane, halothane, other GAs e.g. ketamine, propofol TIVA, and anaesthetic adjuncts such as opioids and benzodiazepines. The primary outcome was: the number of patients with postoperative behaviour disturbance as measured by the authors of the included studies. Two authors independently extracted data using standardized data collection forms. Revman 5 [1] was used for data synthesis and meta-analyses.

Results: 42 trials investigating > 4000 children met criteria for inclusion and 15 trials are awaiting assessment. Main comparisons were: General anaesthetics alone (e.g. TIVA, halothane) vs sevoflurane alone (13 trials); General anaesthetics with adjunct vs sevoflurane with the same adjunct (16 studies); Sevoflurane with an adjunct such as fentanyl or clonidine vs sevoflurane alone (13 studies). General anaesthetics alone resulted in fewer instances of postoperative behaviour disturbance than sevoflurane alone (RR 0.60 95% CI 0.42 to 0.86; 13 trials of 1509 children). For halothane compared with sevoflurane, the relative risk was 0.60 [95% CI 0.46 to 0.79] (7 trials of 825 children) and for the propofol subgroup the relative risk was 0.27 [95% CI 0.14 to 0.51] (2 trials of 222 children). Interim analyses indicate that other regimens also reduce the incidence of behavioural disturbance when compared with sevoflurane.

Conclusions: Postoperative behaviour disturbance is more common with sevoflurane when compared with other general anaesthetics such as halothane or propofol. Other regimens are also likely to show this effect.

References: [1] The Cochrane Collaboration. Review Manager (RevMan) 5.0 for
Windows. The Cochrane Collaboration, 2008. www.cochrane.org